In two to three years, primary care clinics could be popping up in Walmart stores in rural Indiana while most rural Indiana hospitals will offer little to no inpatient services. That’s dramatically different from what we’re used to.
Hoosiers are receiving $11.9 million in rebates this year from health insurers that used less than 80 percent of their 2013 premiums for medical bills last year. That’s down from $22.6 million handed out last year.
Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.
HealthLease Properties REIT, which is led by Mainstreet Property’s Zeke Turner, will be sold to Ohio-based Health Care REIT Inc., along with 17 projects Mainstreet has under construction. The deal includes 45 future projects.
In spite of the beaucoup bucks in the pharma sector, patients, along with their families and committed advocates, are turning out to be better sources of funding for early stage companies because they tolerate risk better than drug companies and investors.
The decline in patient visits slowed a bit for Indiana University Health in the second quarter, allowing the hospital system to use a price increase and cost cuts to significantly boost its operating profit.
Founders of Chondrial Therapeutics believe that if further testing validates their treatment for Friedreich’s ataxia, it could be a blockbuster with annual sales topping $1 billion.
Gov. Mike Pence thinks his HIP 2.0 plan would reform Medicaid in line with conservative principles. To the extent the Obama administration agrees, that’s the biggest hurdle to get the plan approved.
Carmel-based ITT Educational Services no longer has a margin of error, as it tries to dig out from a scuttled real estate deal, tightened rules from lenders and the feds, and its CEO’s pending resignation.
Carmel-based ITT Educational Services Inc. announced late Monday afternoon that CEO Kevin Modany planned to resign within six months. The struggling for-profit education firm has drawn scrutiny from government officials for its marketing and lending practices.
WellPoint saw 218,000 members of its health plans disappear because their employers ended their group plans. Other insurers, however, say small employers are ending their plans more slowly than expected.
Investors seem to have rediscovered the Midwest this year, pouring a record $777 million into 139 companies, according to BioEnterprise. In the first half of 2013, Midwest companies raised $351 million.
The site of the former Wishard Memorial Hospital could become home to a new combined downtown hospital for Indiana University Health.
Indiana University Health fell off U.S. News’ honor roll of the nation’s top 1 percent of hospitals. Because of Obamacare and other trends, perhaps IU Health should be happy about that.
Mayor Greg Ballard on Wednesday proposed a 5-year program to pay for preschool for 4-year-olds from low-income families. He also floated hiring another 280 police officers. The cost to the average household would be $86 per year.
WellPoint Inc.’s profit fell in the second quarter, but still topped Wall Street’s expectations. The health insurer raised its full-year profit forecast and projections for enrollment in its health plans.
With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That’s not the same thing as paying to market drugs, but it’s hardly without controversy.
Results of a Roche clinical trial mirror those produced by an experimental Lilly drug two years ago. Lilly executives say that validates their approach in the multi-billion-dollar race to market the first drug to reverse Alzheimer’s.
The Indiana University School of Medicine plans to hire 100 research professors over the next five years in a bid to vault into the top 25 medical schools.
